Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect.

doi:10.1016/S0149-2918(97)80097-5

Paper

Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect.

Published Jul 1, 1997 · F. Lowe

Clinical therapeutics

Q1 SJR score

82

Citations

3

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Highly Cited

Study Snapshot

Tamsulosin coadministration with nifedipine, enalapril, or atenolol does not require dose adjustment and has a favorable safety profile in patients with benign prostatic hyperplasia.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect.

References

Citations